FPT Hits One Billion USD Revenue in Global IT Services for the First Time
Global technology corporation FPT has surpassed one billion USD in the global IT services segment, generated by its subsidiary FPT Software. This marks FPT as the first Vietnam-headquartered tech firm to reach this milestone, underscoring its sustainable growth, steadfast commitment to innovation, and dedication to client satisfaction.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20231221481561/en/
FPT Software's Board of Management celebrating the ‘billion-dollar revenue' milestone (Photo: Business Wire)
In 2023, the IT firm made monumental strides in expanding its global presence and alliances to deliver successful digital transformation to customers, evident from its elevated strategic partnerships with several industry leaders, including SAP, Microsoft, AWS, Salesforce, and Adobe. As part of FPT's global expansion strategy, it has also inked several investment and acquisition deals with Landing AI, Intertec International, Cardinal Peak, and AOSIS to enhance its competencies and provide closer support to clients in overseas markets. These efforts allow FPT to double its revenue from global IT services in three years, with the largest contribution from its major markets - Japan, the Americas, and Asia Pacific, accounting for roughly 30 percent each.
FPT has established itself as a trusted partner for businesses across several sectors, with digital transformation playing a large role in its end-to-end services and solutions portfolio, accounting for nearly 50% of total global revenue. The corporation has extensive expertise in several domains, including ERP modernization, cloud and data, and software-defined vehicles. The recent launch of FPT Automotive further solidifies its strategic investment and builds on its decade-long experience in automotive product engineering services and solutions.
These achievements are supported by FPT’s human-centric approach to doing business, with its strong commitment to sustainable practices, workplace diversity, and workforce development. It earned EcoVadis Silver rating for its ESG initiatives and was recognized as the ‘Great Place to Work’ in various countries, including Vietnam, Japan, Singapore, the US, and more.
As a world-class technology enabler for complex business challenges and opportunities, FPT anticipates immense global market potential and opportunities to reach more billion-dollar milestones in revenue and profit from a single market, a single vertical industry, and a single contract. Following this direction, the IT firm will continue delivering comprehensive services and solutions, all embedded with artificial intelligence (AI). Its global workforce will be further strengthened with seasoned experts and a robust pipeline of young, skilled IT talents from its home country, Vietnam, and other locations like India, China, the Philippines, and Latin America. At the same time, it will be at the forefront of promoting the momentum of Vietnam as the world's emerging digital hub to help its clients reinvent business excellence and resilience.
“FPT Corporation’s ambition is to showcase Vietnamese intelligence and technology to the global stage, and our subsidiary FPT Software was founded to realize that vision. As the world turns its attention to Vietnam as a prominent hub for business investment and digital innovation, we have proven our pivotal role in driving this movement. In the journey ahead, we will persist as a trusted partner, empowering global enterprises towards a more sustainable and happier future,” said FPT Corporation Founder and Chairman Dr. Truong Gia Binh.
“People development is the foundation for our sustainable growth. This achievement is a testament to the collective efforts and wisdom accumulated across generations of FPT Software's people. We will continue focusing on talent development and equip our people with a happy working environment and the necessary knowledge and skills to keep up with growing market demand and global standards,” said FPT Software Chairwoman Chu Thi Thanh Ha.
“With AI as an accelerator embedded in all services and solutions, we are committed to enabling agility and scalability and optimizing quality and productivity for all projects. Looking forward, we have plans for new partnerships and M&As with leading companies worldwide to enhance our nearshore network expansion, delivery quality, core competencies, and operational excellence to provide end-to-end solutions and better serve our global clients,” said FPT Software CEO Pham Minh Tuan.
As a leader in Vietnam’s nationwide movement of digital transformation, FPT has also set its sights on AI and semiconductor as strategic focuses, with a series of initiatives, including becoming the founding member of the AI Alliance led by IBM and Meta, advancing its strategic partnership with Mila, launching Semiconductor Circuit Faculty and working on collaboration opportunities with world’s leading names in semiconductor like Nvidia. It has obtained orders for nearly 70 million chips, scheduled for delivery by 2025.
About FPT Corporation and FPT Software
FPT Corporation is a global technology corporation and a leader in consulting, providing, and deploying technology and telecommunications services and solutions.
FPT Software, its subsidiary, is a global technology and IT services provider headquartered in Vietnam. The company champions complex business opportunities and challenges with its world-class services in Advanced Analytics, AI, Digital Platforms, Cloud, Hyperautomation, IoT, Low-code, and so on. It has partnered with over 1,000+ clients worldwide, 91 of which are Fortune Global 500 companies in Aviation, Automotive, Banking, Financial Services and Insurance, Healthcare, Logistics, Manufacturing, Utilities, and more. For more information, please visit https://fptsoftware.com/
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20231221481561/en/
Contact information
Media
Mai Duong (Ms.)
FPT Software
PR Manager
MCP.PR@fpt.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Vertex Receives CHMP Positive Opinion for ALYFTREK ® , a New Once-Daily CFTR Modulator for the Treatment of Cystic Fibrosis28.4.2025 09:03:00 EEST | Press release
Vertex Pharmaceuticals (Nasdaq: VRTX) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for ALYFTREK®(deutivacaftor/tezacaftor/vanzacaftor)for the treatment of people with cystic fibrosis (CF) ages 6 years and older who have at least one non-class I mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. “Our goal has always been to serially innovate to help people with cystic fibrosis live healthier and longer lives. If approved, this new medicine would be indicated for people with CF ages 6 years and older with at least one non-class I mutation, meaning more patients would be eligible for a medicine that gets them closer to normal levels of sweat chloride,” said Carmen Bozic, M.D., Executive Vice President, Global Medicines Development and Medical Affairs, and Chief Medical Officer, Vertex. “CFTR modulators have already revolutionized the way we treat CF and I am encoura
Prilenia Enters into a Collaboration and License Agreement with Ferrer for the Commercialization and Co-Development of Pridopidine in Europe and Other Select Markets28.4.2025 08:02:00 EEST | Press release
Prilenia Therapeutics B.V., a biopharmaceutical company driven by an unwavering commitment to scientific excellence and accelerating progress for people affected by Huntington’s disease (HD) and amyotrophic lateral sclerosis (ALS), today announced that it has entered into a collaboration and license agreement with Ferrer for the commercialization and further development of pridopidine in Europe and other select markets. Pridopidine is a potent and highly selective, orally administered sigma-1 receptor (S1R) agonist designed to regulate key neuroprotective mechanisms often impaired in neurodegenerative diseases such as HD and ALS. Under the terms of the agreement, Prilenia will receive an upfront payment of approximately €80 million plus up to €45 million in near-term development, regulatory, and commercial milestones. The total deal is valued at up to approximately €500 million in upfront and total milestone payments. In addition, Prilenia will receive tiered double-digit royalties on
Ferrer Enters Into a Collaboration and License Agreement With Prilenia for the Commercialization and Co-Development of Pridopidine28.4.2025 08:00:00 EEST | Press release
Ferrer, an international B Corp pharmaceutical company with an increasing focus on rare neurological diseases, and Prilenia Therapeutics B.V.,a clinical-stage biotech company, have announced the signing of a strategic co-development and license agreement in which Ferrer obtains the rights to develop, manufacture and commercialize Pridopidine in the European Region, the Middle East and North African Region, the Southern African Region, the Central and South American Region, and the Commonwealth of Independent States Region. Pridopidine, a potent and highly selective, orally administered sigma-1 receptor agonist, designed to regulate key neuroprotective mechanisms that are often impaired in neurodegenerative diseases, is a promising candidate for the treatment of Huntington’s Disease (HD), a rare inherited neurodegenerative disease, with a high unmet medical need1. It has been studied in more than 1,700 people and long-term safety data of up to 7 years duration are available from previou
Innorna Announces FDA Rare Pediatric Disease and Orphan Drug Designations Granted to IN013 for Treatment of Wilson Disease27.4.2025 12:36:00 EEST | Press release
Innorna, a clinical-stage biotechnology company revolutionizing mRNA therapeutics with its innovative lipid nanoparticle (LNP) delivery technology, today announced the U.S. Food and Drug Administration (FDA) has granted both Rare Pediatric Disease Designation (RPDD) and Orphan Drug Designation (ODD) to its investigational mRNA therapy, IN013, for treating Wilson Disease (WD). This dual achievement accelerates the clinical development of IN013, advancing Innorna’s mission to deliver transformative therapies for WD patients. About FDA Designations The Rare Pediatric Disease Designation (RPDD) incentivizes therapies for serious or life-threatening diseases affecting fewer than 200,000 U.S. patients, primarily those aged 18 or younger. Sponsors may qualify for a Priority Review Voucher (PRV) upon approval to expedite FDA review of a subsequent drug application. The Orphan Drug Designation (ODD) supports therapies targeting rare diseases (affecting fewer than 200,000 U.S. patients) by provi
Everen Specialty Appoints Carla Greaves Chief Underwriting Officer25.4.2025 20:00:00 EEST | Press release
Everen Specialty, a Bermuda-based (re)insurer for energy markets worldwide, today announced the appointment of Carla Greaves as its new Chief Underwriting Officer (CUO). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250425273777/en/ Carla Greaves Ms. Greaves will join the Executive Leadership Team of the Everen Group, based in the Bermuda office, later this year. She succeeds Jane Peterson, Interim CUO, who will continue in a consultancy capacity to facilitate the transition. With more than 30 years of underwriting and leadership experience in the (re)insurance industry, Ms. Greaves brings a wealth of expertise and a proven track record of success in the Casualty market where she is recognized for building high-performing teams, driving profitable growth, and successfully navigating complex market environments. Prior to joining Everen Specialty, Ms. Greaves held increasingly senior leadership positions, most recently servin
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom